The study of metabolites from fermentation culture of Alternaria oxytropis
Open Access
- 11 February 2019
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 19 (1) , 1-8
Abstract
The indolizidine alkaloid-swainsonine is produced by an endophytic fungus Alternaria oxytropis, which was isolated from locoweeds. Swainsonine has many biological activities such as anti-tumorigenic, anti-viral and bacteriostatic. However, the full complement of metabolites produced by Alternaria oxytropis is not known. This study is a chemical analysis of Alternaria oxytropis metabolites, which not only unravels the potential compounds from the fermentation broth but also in which solvent are they extracted, facilitating industrial application. Alternaria oxytropis isolated from Oxytropis gansuensis was cultured in Czapek’s medium for 30d to collect the fermentation broth. The fermentation broth is treated with methanol and then evaporated to dryness to obtain a concentrate of the fermentation broth. The concentrate is added with water for the subsequent fractional extraction with petroleum ether, chloroform, ethyl acetate and n-butanol. Different fractions of the extract were eluted by wet packing and dry loading. The obtained eluate was combined by TLC to detect the same fraction, and then characterized by GC-MS and LC-MS. The results of GC-MS showed that 105 different compounds existed in the petroleum ether, chloroform, and ethyl acetate phases of Alternaria oxytropis fermentation broth. Moreover, the results of LC-MS indicated that the fermentation broth of Alternaria oxytropis contained five alkaloids, 2-hydroxy-indolizidine, retronecine, lentiginosine, swainsonine and swainsonine N-oxide. In addition to swainsonine and swainsonine N-oxide, 2-hydroxy-indolizidine, retronecine and lentiginosine were identified as the secondary metabolites of Alternaria oxytropis. Other compounds were also detected including 5,6-dihydroergosterol, eburicol, lanosterol, and L-phenylalanyl-L-proline lactam, which have potential applications as drugs.Keywords
Funding Information
- National Natural Science Foundation (No. 31201958)
- Key Project of Natural Science Foundation of Shaanxi Province (No. 2017JZ004)
- Special Fund for Agro-scientific Research in the Public Interest (No. 201203062)
This publication has 34 references indexed in Scilit:
- Metabolites from Alternaria Fungi and Their BioactivitiesMolecules, 2013
- New secondary metabolites from bioactive extracts of the fungus Armillaria tabescensNatural Product Research, 2012
- Two new species ofUndifilum, fungal endophytes ofAstragalus(locoweeds) in the United StatesBotany, 2012
- Chemical Ecology of Endophytic Fungi: Origins of Secondary MetabolitesChemistry & Biology, 2012
- Abrogation of Complex Glycosylation by Swainsonine Results in Strain- and Cell-specific Inhibition of Prion ReplicationJournal of Biological Chemistry, 2011
- Localization of endophyticUndifilumfungi in locoweed seed and influence of environmental parameters on a locoweed in vitro culture systemBotany, 2010
- Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell linesMolecular Cancer, 2007
- Swainsonine, an Inhibitor of Glycoprotein Processing, Enhances Cytotoxicity of Large Granular LymphocytesScandinavian Journal of Immunology, 1990
- A short, enantioselective synthesis of (-)-swainsonineJournal of the American Chemical Society, 1989
- Loco Intoxication: Indolizidine Alkaloids of Spotted Locoweed ( Astragalus lentiginosus )Science, 1982